Source: Annual Congress 2007 - Epidemiology of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. S. Breekveldt-Postma, J. A. Erkens, R. Aalbers, M. J. T. van de Ven, J. W. J. Lammers, R. M. S. Herings (Utrecht, Groningen, Arnhem, Netherlands). Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands. Eur Respir J 2007; 30: Suppl. 51, 972

Member's Comments

No comment yet.

Related content which might interest you: Societal costs of severe asthma in Sweden Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018 Excess medical costs in patients with asthma and the role of comorbidity Source: Eur Respir J 2016; 48: 1584-1592 Year: 2016 Long-term evaluation of seasonal out-of-pocket medical costs in patients with chronic respiratory disease based on a survey Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 The impact of telemedicine in healthcare demand by patients with severe persistent asthma Source: International Congress 2016 – Abstracts in medical education, the web and the internet Year: 2016 Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Could a domiciliary COPD care management programme be cost-effective in severe COPD patients? Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Clinical characteristics and burden of illness in a cohort of severe asthma patients Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 A national audit of severe life-threatening asthma in Singapore Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 The impact of ethnicity on patients presenting with acute asthma exacerbation: The experiences of an inner city district general hospital Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Factors associated with COPD exacerbation frequency in a UK primary care cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting Source: International Congress 2017 – Asthma management Year: 2017 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Prevalence of uncontrolled severe persistent asthma patients in pneumology and allergy hospital units in Spain Source: Eur Respir J 2007; 30: Suppl. 51, 634s Year: 2007 Factors associated with higher direct costs of exacerbations of chronic bronchitis and COPD in primay care Source: Eur Respir J 2004; 24: Suppl. 48, 410s Year: 2004 Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005